Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
SWOG Cancer Research Network
BeyondSpring Pharmaceuticals Inc.
Hoffmann-La Roche
EVIVE Biotechnology
Teva Branded Pharmaceutical Products R&D, Inc.
Spectrum Pharmaceuticals, Inc
Spectrum Pharmaceuticals, Inc
GOG Foundation
Amgen
Sandoz
Sandoz
GOG Foundation
Sandoz
Radiation Therapy Oncology Group